Geier Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Geier Asset Management's BMY Position: Q2 2021 in Review
Geier Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 1.6% in Q2 2021, selling an estimated $8.93K and leaving 8,285 shares worth $554K. The position accounts for 0.39% of the portfolio, ranked #56.
Geier Asset Management first reported a position in BMY in Q4 2020 and has held it in 3 quarters since. The position peaked at $658K in Q4 2020. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Geier Asset Management held 8,285 shares of Bristol-Myers Squibb worth $554K as of Q2 2021.
- Geier Asset Management sold 137 Bristol-Myers Squibb shares in Q2 2021, an estimated $8.93K.
- Bristol-Myers Squibb made up 0.39% of Geier Asset Management's portfolio in Q2 2021, its #56 holding.
- Geier Asset Management first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 3 quarters since.
- Geier Asset Management's Bristol-Myers Squibb position peaked at $658K in Q4 2020.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Geier Asset Management's 13F filing for Q2 2021, filed 12 Jul 2021.